Literature DB >> 24676545

Increased DNase I activity in diabetes might be associated with injury of pancreas.

Bin Zhu1, Yuewen Gong, Pengmin Chen, Haojun Zhang, Tingting Zhao, Ping Li.   

Abstract

DNase I is an endonuclease responsible to destruction of chromatin during apoptosis. However, its role in diabetes is still unclear. With blood samples from our previous study related to type 2 diabetes, we examined the DNase I activity in the serum of these patients and the role of DNase I in the injury of pancreas was further investigated in rats and INS-1 cells. Serum and pancreatic tissues from human and rats were used for the study. Insulin resistance and diabetes were induced by high fat diet and STZ injection, respectively. DNase I activity was determined by radial enzyme-diffusion method. Expressions of DNase I and caspase-3 in pancreas were determined in rat pancreatic tissues and INS-1 cells. Apoptosis of INS-1 cells was determined by both TUNEL assay and Flow Cytometry. There was a significant elevation of DNase I activity in serum of patients with type 2 diabetes and rats with STZ injection. Moreover, increase in DNase I expression was observed in the pancreas of diabetic person and rats. Furthermore, high glucose induced both DNase I and caspase-3 expression and at the same time increased apoptosis rate of INS-1 cells. In conclusion, elevated DNase I in diabetes may be related to pancreatic injury and could be one of the causes that induce diabetes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24676545     DOI: 10.1007/s11010-014-2043-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Mammalian deoxyribonucleases I are classified into three types: pancreas, parotid, and pancreas-parotid (mixed), based on differences in their tissue concentrations.

Authors:  H Takeshita; K Mogi; T Yasuda; T Nakajima; Y Nakashima; S Mori; T Hoshino; K Kishi
Journal:  Biochem Biophys Res Commun       Date:  2000-03-16       Impact factor: 3.575

2.  Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay.

Authors:  M Macanovic; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1997-05       Impact factor: 4.330

3.  Exposure to chronic high glucose induces beta-cell apoptosis through decreased interaction of glucokinase with mitochondria: downregulation of glucokinase in pancreatic beta-cells.

Authors:  Won-Ho Kim; June Woo Lee; Young Ho Suh; Shin Hee Hong; Joo Sun Choi; Joo Hyun Lim; Ji Hyun Song; Bin Gao; Myeong Ho Jung
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

4.  Characteristics and risk factors for hyperglycemia in Chinese female patients with systemic lupus erythematosus.

Authors:  Y-J Zeng; F-Q Zeng; L Dai; C Yang; B-Z Lin; D-H Zheng; D Liu; L Yan; M Ren; H Cheng
Journal:  Lupus       Date:  2010-08-06       Impact factor: 2.911

5.  Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation.

Authors:  Kajsa Ericson; Christine Gan; Ian Cheong; Carlo Rago; Yardena Samuels; Victor E Velculescu; Kenneth W Kinzler; David L Huso; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-20       Impact factor: 11.205

6.  Apoptotic DNA fragmentation may be a cooperative activity between caspase-activated deoxyribonuclease and the poly(ADP-ribose) polymerase-regulated DNAS1L3, an endoplasmic reticulum-localized endonuclease that translocates to the nucleus during apoptosis.

Authors:  Youssef Errami; Amarjit S Naura; Hogyoung Kim; Jihang Ju; Yasuhiro Suzuki; Ali H El-Bahrawy; Mohamed A Ghonim; Ramadan A Hemeida; Moselhy S Mansy; Jianhua Zhang; Ming Xu; Mark E Smulson; Hassan Brim; A Hamid Boulares
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

7.  Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.

Authors:  Alexandra E Butler; Juliette Janson; Walter C Soeller; Peter C Butler
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

8.  DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features.

Authors:  F Martinez-Valle; E Balada; J Ordi-Ros; S Bujan-Rivas; A Sellas-Fernandez; M Vilardell-Tarres
Journal:  Lupus       Date:  2009-04       Impact factor: 2.911

9.  Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement.

Authors:  Dusan Skiljevic; Ivica Jeremic; Milos Nikolic; Sladjana Andrejevic; Mirjana Sefik-Bukilica; Biljana Stojimirovic; Branka Bonaci-Nikolic
Journal:  Clin Chem Lab Med       Date:  2013-05       Impact factor: 3.694

Review 10.  Diabetes mellitus and the β cell: the last ten years.

Authors:  Frances M Ashcroft; Patrik Rorsman
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

View more
  4 in total

Review 1.  NETs and traps delay wound healing in diabetes.

Authors:  Rachel J Roth Flach; Michael P Czech
Journal:  Trends Endocrinol Metab       Date:  2015-07-31       Impact factor: 12.015

2.  DNase I aggravates islet β-cell apoptosis in type 2 diabetes.

Authors:  Bin Zhu; Lei Zhang; Yue-Ying Zhang; Lei Wang; Xin-Gang Li; Teng Liu; Yu-Ke Fu; Yan-Fei Zheng; Ping Li; Zhi-Gang Zhao
Journal:  Mol Med Rep       Date:  2016-04-11       Impact factor: 2.952

3.  Renoprotective Effect of the Shen-Yan-Fang-Shuai Formula by Inhibiting TNF-α/NF-κB Signaling Pathway in Diabetic Rats.

Authors:  Jie Lv; Zhen Wang; Ying Wang; Weiwei Sun; Jingwei Zhou; Mengdi Wang; Wei Jing Liu; Yaoxian Wang
Journal:  J Diabetes Res       Date:  2017-06-21       Impact factor: 4.011

4.  Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.

Authors:  TingTing Zhao; SiFan Sun; HaoJun Zhang; XiaoRu Huang; MeiHua Yan; Xi Dong; YuMin Wen; Hua Wang; Hui Yao Lan; Ping Li
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.